A 3 year old is receiving VC Vibrating mesh nebulizer
ventilation. A respiratory therapist is
preparing to administer aerosolized Explain:
dornase alfa (Pulmozyme) in-line A. Dornase alfa (Pulmozyme) is not available in DPI form.
with the ventilator. Which of the B. Dornase alfa (Pulmozyme) is not available in MDI form.
following devices should the C. An ultrasonic nebulizer may alter the configuration of the
therapist select to administer the medication.
therapy? D. A vibrating mesh nebulizer will not alter the configuration of the
medication and will not increase volume delivery to the patient.
A. DPI
B. MDI
C. Ultrasonic nebulizer
D. Vibrating mesh nebulizer
A 3 year old is receiving VC Vibrating mesh nebulizer
ventilation. A respiratory therapist is
preparing to administer aerosolized Explain:
dornase alfa (Pulmozyme) in-line A. Dornase alfa (Pulmozyme) is not available in DPI form.
with the ventilator. Which of the B. Dornase alfa (Pulmozyme) is not available in MDI form.
following devices should the C. An ultrasonic nebulizer may alter the configuration of the
therapist select to administer the medication.
therapy? D. A vibrating mesh nebulizer will not alter the configuration of the
medication and will not increase volume delivery to the patient.
a. DPI
b. MDI
c. Ultrasonic nebulizer
d. Vibrating mesh nebulizer
,A 4-day-old, 35 weeks gestational Decrease CPAP to 5 cm H2O
age infant with symptoms of
respiratory distress syndrome is Explain:
receiving an FIO2 of 0.28 and nasal A. PaO2 exposes this infant to an increased risk of developing
CPAP at 8 cm H2O. His vital signs, retinopathy of prematurity.
appearance, and fluid output have B. Discontinuation of CPAP puts the infant at risk of developing
been stable for 12 hours. The results atelectasis and increased shunt. The FiO2 of 0.40 may not result in an
of a blood gas analysis obtained appropriate PaO2.
from an umbilical artery catheter C. Decreasing the CPAP level to 5 cm H2O should allow the PaO2 to
are below: be reduced to a more appropriate level.
D. The hazards associated with 8 cm H2O CPAP are more significant
pH: 7.43 than that of an FIO2 of 0.28; therefore, a better choice is to reduce the
PaCO2: 42 torr CPAP level first. A sudden decrease in FIO2 to 0.21 may result in
PaO2:1 29 torr hypoxemia.
HCO3: 27 mEq/L
BE: +3 mEq/L
Based on this information, a
respiratory therapist should
recommend which of the
following?
A. Maintain the present therapy and
monitor the infant
B. Discontinue CPAP and increase
the FIO2 to 0.40
,C. Decrease CPAP to 5 cm H2O
D. Decrease the FIO2 to 0.21
, A 4-day-old, 35 weeks gestational Decrease CPAP to 5 cm H2O
age infant with symptoms of
respiratory distress syndrome is Explain:
receiving an FIO2 of 0.28 and nasal A. PaO2 exposes this infant to an increased risk of developing
CPAP at 8 cm H2O. His vital signs, retinopathy of prematurity.
appearance, and fluid output have B. Discontinuation of CPAP puts the infant at risk of developing
been stable for 12 hours. The results atelectasis and increased shunt. The FiO2 of 0.40 may not result in an
of a blood gas analysis obtained appropriate PaO2.
from an umbilical artery catheter C. Decreasing the CPAP level to 5 cm H2O should allow the PaO2 to
are below: be reduced to a more appropriate level.
D. The hazards associated with 8 cm H2O CPAP are more significant
pH: 7.43 than that of an FIO2 of 0.28; therefore, a better choice is to reduce the
PaCO2: 42 torr CPAP level first. A sudden decrease in FIO2 to 0.21 may result in
PaO2: 129 torr hypoxemia.
HCO3: 27 mEq/L
BE: +3 mEq/L
Based on this information, a
respiratory therapist should
recommend which of the
following?
A. Maintain the present therapy and
monitor the infant
B. Discontinue CPAP and increase
the FIO2 to 0.40
C. Decrease CPAP to 5 cm H2O
D. Decrease the FIO2 to 0.21
ventilation. A respiratory therapist is
preparing to administer aerosolized Explain:
dornase alfa (Pulmozyme) in-line A. Dornase alfa (Pulmozyme) is not available in DPI form.
with the ventilator. Which of the B. Dornase alfa (Pulmozyme) is not available in MDI form.
following devices should the C. An ultrasonic nebulizer may alter the configuration of the
therapist select to administer the medication.
therapy? D. A vibrating mesh nebulizer will not alter the configuration of the
medication and will not increase volume delivery to the patient.
A. DPI
B. MDI
C. Ultrasonic nebulizer
D. Vibrating mesh nebulizer
A 3 year old is receiving VC Vibrating mesh nebulizer
ventilation. A respiratory therapist is
preparing to administer aerosolized Explain:
dornase alfa (Pulmozyme) in-line A. Dornase alfa (Pulmozyme) is not available in DPI form.
with the ventilator. Which of the B. Dornase alfa (Pulmozyme) is not available in MDI form.
following devices should the C. An ultrasonic nebulizer may alter the configuration of the
therapist select to administer the medication.
therapy? D. A vibrating mesh nebulizer will not alter the configuration of the
medication and will not increase volume delivery to the patient.
a. DPI
b. MDI
c. Ultrasonic nebulizer
d. Vibrating mesh nebulizer
,A 4-day-old, 35 weeks gestational Decrease CPAP to 5 cm H2O
age infant with symptoms of
respiratory distress syndrome is Explain:
receiving an FIO2 of 0.28 and nasal A. PaO2 exposes this infant to an increased risk of developing
CPAP at 8 cm H2O. His vital signs, retinopathy of prematurity.
appearance, and fluid output have B. Discontinuation of CPAP puts the infant at risk of developing
been stable for 12 hours. The results atelectasis and increased shunt. The FiO2 of 0.40 may not result in an
of a blood gas analysis obtained appropriate PaO2.
from an umbilical artery catheter C. Decreasing the CPAP level to 5 cm H2O should allow the PaO2 to
are below: be reduced to a more appropriate level.
D. The hazards associated with 8 cm H2O CPAP are more significant
pH: 7.43 than that of an FIO2 of 0.28; therefore, a better choice is to reduce the
PaCO2: 42 torr CPAP level first. A sudden decrease in FIO2 to 0.21 may result in
PaO2:1 29 torr hypoxemia.
HCO3: 27 mEq/L
BE: +3 mEq/L
Based on this information, a
respiratory therapist should
recommend which of the
following?
A. Maintain the present therapy and
monitor the infant
B. Discontinue CPAP and increase
the FIO2 to 0.40
,C. Decrease CPAP to 5 cm H2O
D. Decrease the FIO2 to 0.21
, A 4-day-old, 35 weeks gestational Decrease CPAP to 5 cm H2O
age infant with symptoms of
respiratory distress syndrome is Explain:
receiving an FIO2 of 0.28 and nasal A. PaO2 exposes this infant to an increased risk of developing
CPAP at 8 cm H2O. His vital signs, retinopathy of prematurity.
appearance, and fluid output have B. Discontinuation of CPAP puts the infant at risk of developing
been stable for 12 hours. The results atelectasis and increased shunt. The FiO2 of 0.40 may not result in an
of a blood gas analysis obtained appropriate PaO2.
from an umbilical artery catheter C. Decreasing the CPAP level to 5 cm H2O should allow the PaO2 to
are below: be reduced to a more appropriate level.
D. The hazards associated with 8 cm H2O CPAP are more significant
pH: 7.43 than that of an FIO2 of 0.28; therefore, a better choice is to reduce the
PaCO2: 42 torr CPAP level first. A sudden decrease in FIO2 to 0.21 may result in
PaO2: 129 torr hypoxemia.
HCO3: 27 mEq/L
BE: +3 mEq/L
Based on this information, a
respiratory therapist should
recommend which of the
following?
A. Maintain the present therapy and
monitor the infant
B. Discontinue CPAP and increase
the FIO2 to 0.40
C. Decrease CPAP to 5 cm H2O
D. Decrease the FIO2 to 0.21
